Works matching IS 18387640 AND DT 2023 AND VI 13 AND IP 14

Results: 23

FN1 mRNA 3'-UTR supersedes traditional fibronectin 1 in facilitating the invasion and metastasis of gastric cancer through the FN1 3'-UTR-let-7i-5p-THBS1 axis.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 5130, doi. 10.7150/thno.82492
By:
- Siwei Pan;
- Jiaming Zhu;
- Pengfei Liu;
- Qiaochu Wei;
- Siyu Zhang;
- Wen An;
- Yuxin Tong;
- Zhenguo Cheng;
- Funan Liu
Publication type:
Article
Targeted elimination of senescent cells by engineered extracellular vesicles attenuates atherosclerosis in ApoE-/- mice with minimal side effects.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 5114, doi. 10.7150/thno.87484
By:
- Liang Zhang;
- Chen Wang;
- Wei Hu;
- Te Bu;
- Wenqi Sun;
- Tian Zhou;
- Shuo Qiu;
- Mengying Wei;
- Helin Xing;
- Zhelong Li;
- Guodong Yang;
- Lijun Yuan
Publication type:
Article
A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumor.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 5099, doi. 10.7150/thno.84946
By:
- Shuyang Sun;
- Ziqiang Ding;
- Li Gao;
- Hammock, Bruce D.;
- Xianing Huang;
- Zhi Ping Xu;
- Xuan Wang;
- Qihong Cheng;
- Fengzhen Mo;
- Wei Shi;
- Shenxia Xie;
- Aiqun Liu;
- Haixia Li;
- Xiaomei Yang;
- Xiaoling Lu
Publication type:
Article
Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 5075, doi. 10.7150/thno.85356
By:
- Minjee Kim;
- Hyeyoung Kim;
- Bu-Gyeong Kang;
- Jooyoung Lee;
- Taegun Kim;
- Hwanho Lee;
- Jane Jung;
- Myung Joon Oh;
- Seungyoon Seo;
- Myung-Jeom Ryu;
- Yeojin Sung;
- Yunji Lee;
- Jeonghun Yeom;
- Gyoonhee Han;
- Sun-Shin Cha;
- Hosung Jung;
- Hyun Seok Kim
Publication type:
Article
Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 5057, doi. 10.7150/thno.84937
By:
- Jinhai Deng;
- Teng Pan;
- Chunxin Lv;
- Lulu Cao;
- Lifeng Li;
- Xingang Zhou;
- Gang Li;
- Huanxin Li;
- Vicencio, Jose M.;
- Yihan Xu;
- Fengxiang Wei;
- Yazhou Wang;
- Zaoqu Liu;
- Guanglin Zhou;
- Mingzhu Yin
Publication type:
Article
Targeting cullin neddylation for cancer and fibrotic diseases.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 5017, doi. 10.7150/thno.78876
By:
- Zhang-Xu He;
- Wei-guang Yang;
- Dan Zengyangzong;
- Ge Gao;
- Qian Zhang;
- Hong-Min Liu;
- Wen Zhao;
- Li-Ying Ma
Publication type:
Article
Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE-/-mice.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4993, doi. 10.7150/thno.87968
By:
- Peng Xiang;
- Qingqiu Chen;
- Le Chen;
- Jin Lei;
- Zhiyi Yuan;
- Hui Hu;
- Yining Lu;
- Xianmin Wang;
- Tingting Wang;
- Ruihong Yu;
- Wanping Zhang;
- Jun Zhang;
- Chao Yu;
- Limei Ma
Publication type:
Article
Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4974, doi. 10.7150/thno.86466
By:
- Han Sun;
- Yu Zhang;
- Jiahui Wang;
- Juncheng Su;
- Dejian Zhou;
- Xiang Yu;
- Yingjie Xu;
- Wen Yang
Publication type:
Article
Polymer theranostics with multiple stimuli-based activation of photodynamic therapy and tumor imaging.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4952, doi. 10.7150/thno.86211
By:
- Tavares, Marina Rodrigues;
- Islam, Rayhanul;
- Šubr, Vladimír;
- Hackbarth, Steffen;
- Shanghui Gao;
- Kai Yang;
- Lobaz, Volodymyr;
- Jun Fang;
- Etrych, Tomáš
Publication type:
Article
Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4936, doi. 10.7150/thno.85711
By:
- Xue Li;
- Ruijun Deng;
- Jie Li;
- Hui Li;
- Zhe Xu;
- Lei Zhang;
- Linyin Feng;
- Chunying Shu;
- Mingming Zhen;
- Chunru Wang
Publication type:
Article
E3 ubiquitin ligase TRIM21 targets TIF1γ to regulate β-catenin signaling in glioblastoma.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4919, doi. 10.7150/thno.85662
By:
- YanLan Li;
- Lingbo Bao;
- Hong Zheng;
- Mingying Geng;
- TianYi Chen;
- Xiaoyan Dai;
- He Xiao;
- Lujie Yang;
- Chengyi Mao;
- Yuan Qiu;
- Yu Xu;
- Dong Wang;
- Meng Xia Li;
- Qian Chen
Publication type:
Article
Detection of lineage-reprogramming efficiency of tumor cells in a 3D-printed liver-on-a-chip model.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4905, doi. 10.7150/thno.86921
By:
- Zuyan Lu;
- Xiangwan Miao;
- Qianqian Song;
- Huifen Ding;
- Rajan, Shiny Amala Priya;
- Skardal, Aleksander;
- Votanopoulos, Konstantinos I.;
- Kerong Dai;
- Weixin Zhao;
- Baisong Lu;
- Atala, Anthony
Publication type:
Article
3D autofluorescence imaging of hydronephrosis and renal anatomical structure using cryo-micro-optical sectioning tomography.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4885, doi. 10.7150/thno.86695
By:
- Guoqing Fan;
- Chenyu Jiang;
- Zhuoyao Huang;
- Mingyu Tian;
- Huijuan Pan;
- Yaru Cao;
- Tian Lei;
- Qingming Luo;
- Jing Yuan
Publication type:
Article
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4872, doi. 10.7150/thno.86831
By:
- Ghosh, Puja;
- Fontanella, Rosaria Anna;
- Scisciola, Lucia;
- Pesapane, Ada;
- Taktaz, Fatemeh;
- Franzese, Martina;
- Puocci, Armando;
- Ceriello, Antonio;
- Prattichizzo, Francesco;
- Rizzo, Maria Rosaria;
- Paolisso, Giuseppe;
- Barbieri, Michelangela
Publication type:
Article
Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4858, doi. 10.7150/thno.86770
By:
- Bragina, Olga;
- Chernov, Vladimir;
- Larkina, Mariia;
- Rybina, Anstasiya;
- Zelchan, Roman;
- Garbukov, Eugeniy;
- Oroujeni, Maryam;
- Loftenius, Annika;
- Orlova, Anna;
- Sörensen, Jens;
- Frejd, Fredrik Y.;
- Tolmachev, Vladimir
Publication type:
Article
Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4+ T cells through regulating type 2 conventional dendritic cells.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4836, doi. 10.7150/thno.86792
By:
- Jing Luo;
- Shuju Pang;
- Zhenzhen Hui;
- Hua Zhao;
- Shilei Xu;
- Wenwen Yu;
- Lili Yang;
- Qian Sun;
- Xishan Hao;
- Feng Wei;
- Jian Wang;
- Xiubao Ren
Publication type:
Article
Developing an efficient MGCR microneedle nanovaccine patch for eliciting Th 1 cellular response against the SARS-CoV-2 infection.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4821, doi. 10.7150/thno.83390
By:
- Ang Gao;
- Yunsheng Chen;
- Hui Liang;
- Xinyuan Cui;
- Amin Zhang;
- Daxiang Cui
Publication type:
Article
5-aminolevulinate and CHIL3/CHI3L1 treatment amid ischemia aids liver metabolism and reduces ischemia-reperfusion injury.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4802, doi. 10.7150/thno.83163
By:
- Guanghui Jin;
- Na Guo;
- Yasong Liu;
- Lele Zhang;
- Liang Chen;
- Tao Dong;
- Wei Liu;
- Xiaomei Zhang;
- Yong Jiang;
- Guo Lv;
- Fei Zhao;
- Ziqing Hei;
- Yang Yang;
- Jingxing Ou
Publication type:
Article
Advanced hitchhiking nanomaterials for biomedical applications.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4781, doi. 10.7150/thno.88002
By:
- Ying Wang;
- Shao-Kai Sun;
- Yang Liu;
- Zhanzhan Zhang
Publication type:
Article
Three-dimensional nanofibrous sponges with aligned architecture and controlled hierarchy regulate neural stem cell fate for spinal cord regeneration.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4762, doi. 10.7150/thno.87288
By:
- Zhiwei Li;
- Ye Qi;
- Lei Sun;
- Zheng Li;
- Shaojuan Chen;
- Yuqi Zhang;
- Yuan Ma;
- Jinming Han;
- Zide Wang;
- Yulin Zhang;
- Huimin Geng;
- Bin Huang;
- Jian Wang;
- Gang Li;
- Xingang Li;
- Shaohua Wu;
- Shilei Ni
Publication type:
Article
A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to 177Lutetium-DOTA-octreotate radionuclide therapy.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4745, doi. 10.7150/thno.84628
By:
- Waldeck, Kelly;
- Van Zuylekom, Jessica;
- Cullinane, Carleen;
- Gulati, Twishi;
- Simpson, Kaylene J.;
- Tothill, Richard W.;
- Blyth, Benjamin;
- Hicks, Rodney J.
Publication type:
Article
Nuclear translocation of thioredoxin-1 promotes colorectal cancer development via modulation of the IL-6/STAT3 signaling axis through interaction with STAT3.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4730, doi. 10.7150/thno.85460
By:
- Aihua Wu;
- Daoquan Fang;
- Yangyang Liu;
- Xiaomeng Shi;
- Zuyue Zhong;
- Baojian Zhou;
- Lechi Ye;
- Xuecheng Sun;
- Lei Jiang
Publication type:
Article
Tuning ultrasmall theranostic nanoparticles for MRI contrast and radiation dose amplification.
Published in:
Theranostics, 2023, v. 13, n. 14, p. 4711, doi. 10.7150/thno.85663
By:
- Brown, Needa;
- Rocchi, Paul;
- Carmès, Léna;
- Guthier, Romy;
- Iyer, Meghna;
- Seban, Léa;
- Morris, Toby;
- Bennett, Stephanie;
- Lavelle, Michael;
- Penailillo, Johany;
- Carrasco, Ruben;
- Williams, Chris;
- Huynh, Elizabeth;
- Zhaohui Han;
- Kaza, Evangelia;
- Doussineau, Tristan;
- Toprani, Sneh M.;
- Qin, Xingping;
- Nagel, Zachary D.;
- Sarosiek, Kristopher A.
Publication type:
Article

Works matching IS 18387640 AND DT 2023 AND VI 13 AND IP 14

FN1 mRNA 3'-UTR supersedes traditional fibronectin 1 in facilitating the invasion and metastasis of gastric cancer through the FN1 3'-UTR-let-7i-5p-THBS1 axis.

Targeted elimination of senescent cells by engineered extracellular vesicles attenuates atherosclerosis in ApoE<sup>-/-</sup> mice with minimal side effects.

A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumor.

Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy.

Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer.

Targeting cullin neddylation for cancer and fibrotic diseases.

Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE<sup>-/-</sup>mice.

Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome.

Polymer theranostics with multiple stimuli-based activation of photodynamic therapy and tumor imaging.

Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome.

E3 ubiquitin ligase TRIM21 targets TIF1γ to regulate β-catenin signaling in glioblastoma.

Detection of lineage-reprogramming efficiency of tumor cells in a 3D-printed liver-on-a-chip model.

3D autofluorescence imaging of hydronephrosis and renal anatomical structure using cryo-micro-optical sectioning tomography.

Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists.

Phase I clinical evaluation of <sup>99m</sup>Tc-labeled Affibody molecule for imaging HER2 expression in breast cancer.

Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4<sup>+</sup> T cells through regulating type 2 conventional dendritic cells.

Developing an efficient MGCR microneedle nanovaccine patch for eliciting Th 1 cellular response against the SARS-CoV-2 infection.

5-aminolevulinate and CHIL3/CHI3L1 treatment amid ischemia aids liver metabolism and reduces ischemia-reperfusion injury.

Advanced hitchhiking nanomaterials for biomedical applications.

Three-dimensional nanofibrous sponges with aligned architecture and controlled hierarchy regulate neural stem cell fate for spinal cord regeneration.

A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to <sup>177</sup>Lutetium-DOTA-octreotate radionuclide therapy.

Nuclear translocation of thioredoxin-1 promotes colorectal cancer development via modulation of the IL-6/STAT3 signaling axis through interaction with STAT3.

Tuning ultrasmall theranostic nanoparticles for MRI contrast and radiation dose amplification.